Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.

Joanne BrittoAnne HolbrookHaowei SunChristine Cserti-GazdewichOksana Prokopchuk-GaukCyrus HsiaKarima KhamisaPaul R YensonMichelle SholzbergHarold J OlneySudeep ShivakumarDavid JonesHayley MerkeleyJacqueline CostelloErin JamulaDonald M Arnold

Published in: Clinical and investigative medicine. Medecine clinique et experimentale (2024)

TPO-RAs are effective second-line therapies for the treatment of ITP; however, access is variable across Canada, which results in health disparities and poor uptake of international treatment guidelines.

Keyphrases

healthcare
combination therapy
health information
replacement therapy
smoking cessation
health promotion
adverse drug